RedX Pharma CEO focuses on pipeline that found Lilly’s rising starBack in 2017, the UK biotech RedX Pharma had to sell its prized asset after administrators stepped in Share XRedX Pharma CEO focuses on pipeline that found Lilly’s rising starhttps://pharmaphorum.com/news/redx-looks-to-keep-pipeline-assets-after/
Redx shares soar after IPF drug licence deal with AstraZenecaShares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to Share XRedx shares soar after IPF drug licence deal with AstraZenecahttps://pharmaphorum.com/news/redx-shares-soar-after-ipf-drug-deal-with-astrazeneca/
